Abstract:OBJECTIVE: To investigate the hypothesis that amyloid-β (Aβ) induces NLRP1-dependent neuronal pyroptosis in the pathogenesis of Alzheimer9s disease (AD) in vitro and in vivo. BACKGROUND: Increasing evidence has shown the aberrant expression of inflammasome related proteins in AD brain; these proteins, including NLRP1 inflammasome, are implicated in the execution of inflammatory response and pyroptotic death. Although current data are associated NLRP1 genetic variants with AD, the involvement of NLRP1 inflammasome in AD pathogenesis is still unknown. DESIGN/METHODS: The involvement of NLRP1 in Aβ induced neuronal pyroptosis was confirmed by silencing of NLRP1 in primry cortical neurons. Cell viability and pyroptosis cells were determined by MTT assay and TUNEL assay. Levels of inflammatory cytokine in cell culture supernatants were measured by ELISA kit. In addition, we employed direct in-vivo infusion of nonviral small interfering RNA to knockdown NLRP1 or caspase-1 in APPswe/PS1dE9 brain. The spatial learning and momery performance was detected by Morris water maze. The distribution of Aβ was assessed by immunohistochemical analysis in brain section. And the neuronal pyroptosis was observed by TUNEL assay. RESULTS: Using APPswe/PS1dE9 transgenic mice, we found that cerebral NLRP1 levels were up-regulated. Our in-vitro studies further showed that increased NLRP1 mediated caspase-1-dependent ‘pyroptosis’ in cultured cortical neurons in response to Aβ. Moreover, we employed direct in-vivo infusion of nonviral small interfering RNA to knockdown NLRP1 or caspase-1 in APPswe/PS1dE9 brain, and discovered that these NLRP1 or caspase-1 deficiency mice resulted in significantly reduced neuronal pyroptosis and reversed cognitive impairments. CONCLUSIONS: Our findings indicate an important role for NLRP1/caspase-1 signaling in AD progression, and point to the modulation of NLRP1 inflammasome as a promising strategy for AD therapy. Disclosure: Dr. Tan has nothing to disclose. Dr. Yu has nothing to disclose. Dr. Jiang has nothing to disclose. Dr. Zhu has nothing to disclose. Dr. Wang has nothing to disclose. Dr. Jia has nothing to disclose. Dr. Tan has nothing to disclose.

The Protective Effect of IDO1 Inhibition in Aβ-Treated Neurons and APP/PS1 Mice

Microbiota-derived metabolite Indoles induced aryl hydrocarbon receptor activation and inhibited neuroinflammation in APP/PS1 mice

Downregulating expression of OPTN elevates neuroinflammation via AIM2 inflammasome- and RIPK1-activating mechanisms in APP/PS1 transgenic mice

The IDO Inhibitor Coptisine Ameliorates Cognitive Impairment in a Mouse Model of Alzheimer's Disease.

Long-term inhibition of ODC1 in APP/PS1 mice rescues amyloid pathology and switches astrocytes from a reactive to active state

Indoleamine 2,3-Dioxygenase: The Key to Pathogenesis and Treatment of Alzheimer’s and Related Neurodegenerative Diseases

A Study on Inhibition of the Aβ1-42-induced Inflammatory Response by the Huatuo Zaizao Pill Through the NF-κB Signaling Pathway.

Anti-inflammatory Activity of a Polypeptide Fraction From Achyranthes bidentate in Amyloid β Oligomers Induced Model of Alzheimer’s Disease

Programmed Cell Death Protein 1 Blockade Reduces Glycogen Synthase Kinase 3β Activity and Tau Hyperphosphorylation in Alzheimer’s Disease Mouse Models

Liver X Receptor Activation Attenuates Inflammatory Response and Protects Cholinergic Neurons in App/Ps1 Transgenic Mice

Amyloid-β Induces NLRP1-Dependent Neuronal Pyroptosis in Alzheimer's Disease (P1.239)

Inhibition of NLRP1 inflammasome improves autophagy dysfunction and Aβ disposition in APP/PS1 mice

EK100 and Antrodin C Improve Brain Amyloid Pathology in APP/PS1 Transgenic Mice by Promoting Microglial and Perivascular Clearance Pathways

Development and Optimization of a Target Engagement Model of Brain IDO Inhibition for Alzheimer's Disease

Ginsenoside Rg1 alleviates learning and memory impairments and Aβ disposition through inhibiting NLRP1 inflammasome and autophagy dysfunction in APP/PS1 mice

Pinoresinol diglucoside attenuates neuroinflammation, apoptosis and oxidative stress in a mice model with Alzheimer's disease

Orientin Alleviates Cognitive Deficits and Oxidative Stress in Aβ1–42-induced Mouse Model of Alzheimer's Disease

Inhibition of interleukin-1β plays a protective role in Alzheimer’s disease by promoting microRNA-9-5p and downregulating targeting protein for xenopus kinesin-like protein 2

Potential Roles of Hypoxia-Inducible Factor-1 in Alzheimer's Disease: Beneficial or Detrimental?

Inhibition of TLR4 Induces M2 Microglial Polarization and Provides Neuroprotection via the NLRP3 Inflammasome in Alzheimer’s Disease

Silencing of LRP1 Exacerbates Inflammatory Response Via TLR4/NF-κB/MAPKs Signaling Pathways in APP/PS1 Transgenic Mice